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Abstract
Objectives MR imaging of neonates is difficult for many reasons and a major factor is safe transport to the MR facilities. In this
article we describe the use of a small, investigational 3-T MR customised for brain imaging and sited on a neonatal unit of a
tertiary centre in the UK, which is in contrast to a 300-m journey to the whole-bodyMR scanner used at present for clinical cases.
Methods We describe our methods for preparing babies for safe transport and scanning on an investigational 3-TMR scanner on
a neonatal unit and the development of appropriate MR sequences. The MR scanner does not have CE marking at present so this
early development work was undertaken on normal neonates whose parents consented to a research examination.
Results Fifty-two babies were scanned and there were no serious adverse events. The MR examinations were considered to be
diagnostically evaluable in all 52 cases and in 90% the imaging was considered to be at least as good as the quality obtained on
the 1.5-T scanner currently used for clinical cases.
Conclusion We have shown that this investigational 3-T MR scanner can be used safely on a neonatal unit and we have refined
the MR sequences to a point that they are clinically usable.
Key Points
• Access to neonatal MR imaging is limited.
• We describe an investigational 3-T MR scanner site on a neonatal unit.
• The scanner produces images suitable for clinical practice.
Keywords Magnetic resonance imaging .Magnetic resonance spectroscopy .Magnetic resonance angiography . Neonate . Brain
Abbreviations
cUSS Cranial ultrasonography
CE European conformity
MHRA Medicines and Healthcare Products Regulatory
Agency of the United Kingdom
MR Magnetic resonance
SAR Specific absorption rate
US FDA United States Food and Drug Administration
Introduction
Magnetic resonance (MR) imaging has revolutionised the
assessment of the brain in clinical practice and is the most
accurate radiological method for detecting most brain pa-
thologies in most age groups. The ability of MR imaging
to produce high spatial and contrast resolution images
without exposure to ionising radiation has ensured rapid
clinical uptake. One group that has not benefited from
MR imaging as much as others is neonates, in whom
MR imaging of the brain is difficult. There is inherently
poor contrast resolution in the neonatal brain due to its
immature state of myelination and obtaining high-quality
MR images in a non-sedated/non-anaesthetised baby is
challenging because of movement.
A further problem is ensuring safe transfer of the baby from
the neonatal units to the MR scanner. Many neonates who
may benefit from MR imaging of their brain have unstable
cardiovascular and respiratory function and transfer to theMR
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scanners (usually in a different part of the hospital or at a
different hospital) introduces extra risk. The decision to per-
form a clinical procedure, including a diagnostic test, should
be considered on the basis of a risk/benefit analysis and, for
neonates, the decision is often not to perform MR imaging. In
such cases, transfontanelle cranial ultrasound scanography
(cUSS) is often relied upon as it can be done on the neonatal
wards and has been used successfully over many years. These
factors are well illustrated in a short educational video made at
Sheffield Teaching Hospital by the Wellcome Trust [1].
It has been a long-term aim of our group to improve access
to MR imaging of the brain in neonates and in this article we
describe our initial experience of using a physically small, but
high field MR scanner installed in the neonatal unit.
Methods
The investigational high-field (3-T) neonatal MR scanner MR
employed in this study was designed and built by GE
Healthcare, Milwaukee, WI, USA, and can be sited on non-
reinforced office floors (weight 500 kg) in an area of approx-
imately 6 m2 including scan control and equipment rooms
(Fig. 1). It is designed to have the full capability of a current
clinical MR system but customised to scan neonatal brains. It
was installed on the Neonatal Unit of our institution resulting
in much shorter journeys for neonates to have a MR scan in
comparison with the 300 m (including two lift journeys) to the
existing MR facility in the radiology department. The 3-T
static magnet is a closed loop cryogenic system with a low
helium volume (30 l), which maintains the magnet at 4.2 K.
The 5-Gauss fringe field is contained within the scanner room
(2.0 m × 1.3 m) and has a field uniformity of 15 ppm within a
15-cm-diameter sphere at the iso-centre. The maximum gra-
dient strength is 70 mT/m and the maximum slew rate is 300
T/m/s. dB/dt is kept below the FDA guidelines of 300 mT/m/
ms by software and hardware control. The RF power of the
transmitter is set at 4 kW to allowmaximum SAR levels in the
range of 2W/kg for babies weighing up to 6 kg. The magnet
bore has 28.0 cm diameter and 50 cm length, the gradient bore
is 21.8 cm and the internal diameter of the quadrature
transmit-receive RF coil is 17.9 cm, which is the only coil
available at present. The magnet, gradients and RF systems
are linked to a clinical ‘front-end’ running software at release
level DV25.0.
Ethical approval
The investigational MR scanner currently has neither US
Food and Drug Administration (US FDA) approval nor
European Conformity (CE) marking, so its use was governed
by theMedicines and Healthcare products Regulatory Agency
(MHRA) of the UK. The MHRA specified that the system
could not be used for primary diagnostic purposes and the
manufacturer should be the sponsor of the study. Ethics ap-
proval for enrolment of up to 60 subjects was granted by a
specialist paediatric Research Ethics Committee, which
allowed the researchers to approach the families of two
groups:
Group 1.Normal babies born at term (≥ 37 weeks gesta-
tional age, GA) whose parents agreed to have an MR
study before the baby was discharged
Group 2.Premature babies that were about to go home at
term-corrected age and had had clinical neuroimaging
studies (cUSS) performed at an earlier date
All parents provided written, informed consent.
Safety issues and patient handling
The pre-checks and preparation for the MR scan were carried
out by one of two specialist research nurses associated with
the study (PB, JC). The scans were scheduled to be within 1 h
of the baby being fed. We confirmed that the baby’s head
would fit into the scanner by using a soft template with the
same internal diameter as the scanner before leaving the ward.
None of the recruited babies were excluded on the basis of
head size and there were no scan failures due to head size.
There are no specific safety concerns about exposing a neo-
nate to a 3-T static magnetic field [2], although the strong field
gradient at the entry to this magnet (39.8 T/m) requires a strict
protocol to prevent ferromagnetic materials from entering the
scan room. Parents completed MR safety screening forms for
their baby and themselves, as one parent was allowed to ac-
company their baby during scanning. Any monitoring device
or other equipment not compatible with MR scanning was
removed, and the baby was changed into a Velcro-fastened
vest. Screening for metal was completed on arrival at the
MR unit by the radiographer (DJ) who ensured all ferromag-
netic personal items were removed from the adults and visual
inspections of the baby were supplemented by the use of a
hand-held metal detector.
Body temperature was first measured on the ward using a
hand-held electronic thermometer and on arrival at the scanner
control room. A disposable temperature probe was attached to
the baby’s axilla and once the baby was on the scanner the
probe was connected to anMR-compatible monitoring system
(Invivo Expression MR400, Philips Healthcare, Eindhoven,
The Netherlands). Temperature was monitored continuously
during scanning, along with heart rate and the oxygen satura-
tions of the baby. The temperature was recorded on return to
the ward. A further issue is the acoustic noise created by the
scanner, which can have equivalent continuous sound levels
of around 102 db (A) for some of the planned MR sequences.
As such, noise reduction of at least 22 dB was required to
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comply with the IEC 60601-2-33 standards and was achieved
by a combination of earplugs and ear protectors. Mack’s®
mouldable earplugs (McKeon Products, Inc., Warren, MI)
gave a noise reduction rating of 22 dB (manufacturer’s data)
and the additional use of MiniMuffs® (Natus Medical Inc.
Pleasanton, CA) provided an extra 7-dB noise reduction
(manufacturer’s data).
Babies were transferred from the ward to the MR suite in
their standard-care cot by the specialist research nurse accom-
panied by the parent(s) (Fig. 2). The baby was placed in a
disposable sling, which swaddled them closely to minimise
motion, help maintain body temperature and provide a secure
method of transfer into the cradle of the scanner. The scan
cradle is built into the scan table, which is detached from the
scanner and brought into the control room. The scan table
holding the baby was then taken into the scan room and man-
ually docked with the scanner. A slide system with dual rulers
on the bed and scan cradle were used to position the baby’s
head at the iso-centre of the scanner without the need for
electrical drives for the table or positioning lasers. In the event
of an emergency or subject distress, the bed can be rapidly
detached from the scanner and brought into the scan control
room, where appropriate care can be provided.
MR methods
Exposure to the magnetic field was limited to 1 h, including
time allowed for acclimatisation to the scan room, monitoring
at the start and end of scanning, and positioning of the baby in
the scanner. The research nurse stayed with the baby during
scanning for visual monitoring and to stop the scan if there
was any concern. Approximately 40 min of image acquisition
time was available during an uneventful scan event. We
wanted to optimise a full range of imaging sequences (includ-
ing MR angiography) on the investigational scanner to mirror
our current clinical MR imaging protocol performed on a 1.5-
T scanner (Table 1). Development of the MR protocol in-
volved refining and trialling a single sequence before focusing
on the next sequence. To begin with the imaging parameters
for the T2-weighted imaging were modified until the optimal
contrast, resolution and scan time were achieved for both ul-
trafast single shot fast spin echo and T2 FSE imaging. Those
optimised sequences were acquired in all subsequent cases
and long TE single voxel proton spectroscopy and T1-
volume imaging sequences were added and trialled in cases
6-11. Diffusion-weighted imaging and susceptibility-
weighted imaging (both gradient echo T2* and sensitivity-
weighted imaging) were added in cases 9-13. MR arteriogra-
phy and venography sequences were evaluated and refined
during the scans on cases 13-18. All sequences were acquired
in cases 20-49 with further fine-tunings to ensure full optimi-
sation. The last five cases were scanned with a protocol pro-
vided by the sponsor of the research study to provide the data
suitable for application for CE marking.
The images from each baby were reviewed immediately
after the study by one or both of the two paediatric neuroradi-
ologists involved in the study (DJAC, PDG) to report any
unexpected intracranial findings to the neonatal staff. Two to
three weeks later the images were formally reviewed for the
purpose of the study by both reporters by consensus to assess
the quality of the imaging and recommend any changes to the
sequence parameters for future scanning. The neuroradiology
reporters were asked to rate the overall quality of the imaging
data set as either (1) fully evaluable (each sequence is of di-
agnostic quality), (2) partially evaluable (some sequences de-
graded but a clinical report would have been possible) or (3)
Fig. 1 The GE Healthcare
investigational 3-T neonatal MR
system installed at Sheffield
Teaching Hospital and a plan of
the MR suite showing the
proximity to the neonatal
intensive care unit and delivery
suite. The scanner control, scan
room and equipment room
occupy a floor space of 6.0 m ×
6.5 m
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not evaluable, i.e. a clinical report could not have been made.
The assessors were also asked to compare a number of aspects
of image quality against the current reference standard at our
institution, namely MR imaging at 1.5 T. ‘Poor’ was used if
the quality measures were worse than the current clinical stan-
dard, ‘average’ if comparable and ‘good’ if better than current
1.5-T images.
Results
Fifty-four subjects were consented but in one case consent
was withdrawn before the MR study was performed, and in
another case, MR scanning was attempted but no diagnostic
images were obtained because of equipment failure. Of the 52
babies with successful MR imaging, 60% were born at term
and approximately 40% were born before 37 weeks GA. The
median corrected gestational age at the time of the MR study
was 39 weeks (interquartile range 36-40, full range 34-43
weeks GA), median weight was 2.8 kg (interquartile range
2.4-3.4 kg, full range 1.3-4.5 kg) and median head circumfer-
ence 34.0 cm (interquartile range 32.6-35.8 cm, full range
28.3-39.0 cm). There was one reportable adverse event—a
term baby with a pre-existing baseline bradycardia was
recognised as having bradycardia during scanning. A 12-
lead ECG study had confirmed normal sinus rhythm previous-
ly and the bradycardia was judged not to be attributable to the
MR scan so the baby was discharged on the day of the scan
and did not meet the local criteria for follow-up.
The MR imaging studies were considered to be evaluable
in 52/52 (100%) subjects, of which 22/52 (42%) were fully
evaluable and 30/52 (58%) were partially evaluable (Figs. 3
and 4). The image quality was judged to be at least compara-
ble to the clinical 1.5-T scanner in 47/52 (90%) of cases and
better in 34/52 (65%). Similar results were found for image
contrast, signal-to-noise ratio, tissue contrast and homogenei-
ty. The worst results were for artefacts, which were thought to
be worse than expected at 1.5 T in 13/52 (25%) of cases
(Table 2) and were predominantly due to subject movement.
Two babies had unexpected intracranial findings on their MR
examinations that required input from the neonatology staff:
Case A (Fig. 5).A boy born at 37 weeks GA and scanned
on day 1. Haemosiderin staining of the ependyma was
shown in both occipital horns and caudate-thalamic
notches consistent with earlier haemorrhage. Clinical re-
view the following day was unremarkable and the baby
was allowed home with no planned follow-up.
Case B (Fig. 6). A boy born at 37 weeks GAwas scanned
on day 2. There was a small intra-ventricular haemor-
rhage and a developmental venous anomaly in the right
frontal lobe. Clinical review the following day was unre-
markable and the baby was discharged. He was reviewed
in clinic at 2 months and was developing normally.
Discussion
We have demonstrated that a physically small, 3.0-T MR
scanner is a feasible option for imaging the neonatal brain
Fig. 2 Preparation of a baby for MR scanning on the GE Healthcare
investigational 3-T neonatal MR scanner illustrated by a ‘mock’ case
using a mannequin and research staff (see text for full details). The
baby is changed into clothes with no ferro-magnetic components on the
ward and an axillary temperature probe is attached (a). After transfer to
the atrium in the MR suite the baby is re-checked for absence of ferro-
magnetic items and earplugs, ear defenders and a vital sign monitor are
applied (b). The baby is placed in a transport sling (c) and transferred on
to the scan cradle of the tabletop, which has been detached from the MR
scanner (d). The table and baby are pushed into the scanner room (e), the
table is dockedwith a scanner and the cradle manually slid into the bore of
the MR scanner (f). Close-up images of the scanner/table docking
mechanism are shown in g to i
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Table 1 Summary of optimised MR sequence data used in the present study
Sequences for vascular imaging
2D T2
ssFSE
3D FSPGR
T1 Volume
2D Propeller
DWI
2D GE 2D T2 FSE 3D SWAN
(susceptibility-
weighted imaging)
Single-voxel
spectroscopy
3D MRA
(time of flight)
3D MRV
(phase contrast)
Repetition time (TR) 908 (min) 10 6262 600 7000 57.5 1500 21 35
Time to echo (TE) 140 Minimum full 60 15 124 23 144 3.4 5
Flip angle 90 8 110 15 142 25 90 20 10
Bandwidth (KHz) 31.25 15.6 50 15.6 15.6 31.3 27.8 21
Prep time - 900 - - - - - - -
Echo train length - 20 - 16 5 - - -
NEX (signal averages) 0.55 0.75 2 2 2 0.7 1 0.63
Slice thickness/slice gap (mm) 3/0 1.0/0 4/0 3.0/0.3 3/0 3/0 15 1/0 2.4/0
Field of view (cm) 16 × 14.4 18 × 12.6 16 × 16 16 × 12 16 × 14.4 16 × 11.2 1.5 × 1.5 20 × 14 20 × 13
Freq/phase matrix 256/192 256/192 128/128 156/192 256/192 256/192 384/224 320/192
Interpolated matrix and slice thickness 512/384/0.5 512/384/1.5 256/384/1.5 384/224/0.5 320/384/1.2
b Value - - 1000 - - - - - -
Scan time (s) 29 264 192 180 231 173 140 240 364
Additional Flow comp. Flow comp. Flow comp. VENQ = 10
44
42
Eu
r
R
ad
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l
(2018
)
28:44
38
–
44
46
on a neonatal unit without the need for additional major struc-
tural alterations. There are other methods for improving access
to neonatal MR imaging such as MR-compatible transport
incubators, which reduces the number of times the baby has
to be handled during transfer and provides a controlled phys-
ical environment during scanning. The MR compatible
transport incubator has a built-in MR coil allowing the baby
to go into the scanner while in the incubator thereby reducing
the number of handling events. Our group was involved in the
early prototype trials of one such transport incubator system
[3] and we have designed and built our own MR-compatible
incubator [4], which is used clinically.
Fig. 4 Representative images from a normal baby born at term showingMR arteriography andMR venography image sequences optimised in cases 13-
18 in this study
Fig. 3 Representative MR images from a normal baby born at term showing the range of routine sequences acquired in cases 20-49 in this study
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We maintain that an MR scanner on the neonatal unit is a
fundamentally superior approach. It is generally not possible
to install whole-body MR scanners on the neonatal unit in
most hospitals because of the space required and floor load-
ing. Hospitals with a whole-body MR scanner installed in the
NICU have usually done so by designing a new department.
Other groups have approached the problem by developing
MR services optimised to meet the needs of imaging neonates
on standard clinical MR scanners (1.5 T and 3 T) by using
tailored equipment and/or care measures [5, 6]. There have
also been other attempts to construct small footprint systems
for neonatal imaging. Our group previously reported experi-
ence of using a 0.2-T permanent magnet system for neonatal
imaging [7]. More recent developments have used a 0.023 T
system [8] and the US FDA has recently cleared a small, 1.0-T
neonatal MR system for neonatal use [9]. We came to the
conclusion, based on our experience of neonatal imaging at
0.2 T, that the detailed requirements for neonatal brain imag-
ing (e.g. spectroscopy, diffusion imaging, MR angiography)
include at least 1.5 T. A similar view was reached by Tkach
who successfully developed a small-footprint 1.5-T system
sited on a neonatal unit that can image several anatomical
areas [10]. They have subsequently reported their experience
of imaging 492 premature neonates [11]. We believe that the
theoretical improvements in the signal-to-noise ratio provided
by imaging at 3 T offer the best potential imaging for the
neonatal brain because of the requirements of high-quality
multi-sequence imaging/spectroscopy in as short a time as
possible. It should be noted that the US FDA guidelines con-
firm that MR devices with main static magnetic fields of ≤ 4.0
T should be classified as a ‘non-significant risk’ for neonates
[12]. There are disadvantages of scanning at 3 T, however,
such as increased SAR, increased acoustic noise and more
artefacts arising from, for example, susceptibility effects and
field homogeneity problems. The problem with artefacts is
compounded by the small size of the investigational 3-T neo-
natal scanner and our clinical readers considered MR artefacts
to be a concern in 25% of cases (although all cases were
considered to be of diagnostic quality).
The safety of the babies was of paramount importance and
required close collaboration between the MR and neonatal
unit staff involved in transfer and scanning so that rapid as-
sessment and transfer of babies back to the wards could be
made if necessary. This was not required in any of the 52
babies scanned in this study although a consultant-level opin-
ion was sought in three cases (one baby with a bradycardia
and two babies with unexpected intra-cranial findings). The
increased acoustic noise associated with using a 3-TMR scan-
ner was successfully managed by the use of two types of ear
protection. One of the major factors that influences image
quality in neonatal imaging is movement of the baby and we
have taken a feed and swaddle approach, which appears high-
ly beneficial for settling the babies. Only 1 of 52 of the scans
was stopped early because of subject movement and that ex-
amination was considered to be partially evaluable by the
assessors. Close physiological monitoring of the babies did
Fig. 5 Representative axial
gradient echo T2* images from
case A described in the text
showing small areas of
haemosiderin staining in the
caudate-thalamic notches
bilaterally consistent with
previous haemorrhage into the
remnants of the germinal matrix
(arrowed, c)
Table 2 Imaging quality
assessments made by the
paediatric neuroradiology experts
Poor Average Good Percentage of ‘average’
or ‘good’ cases
Overall image quality 5 13 34 90%
Image contrast 4 8 40 92%
Presence of artefacts 13 20 19 75%
Signal-to-noise ratio (SNR) 7 7 38 87%
Tissue contrast 2 9 41 96%
B0 inhomogeneity leading to fat/water separation 0 22 30 100%
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not reveal any adverse effects leading to problems with
desaturation or thermoregulation. Our results showed no prob-
lems with temperature control and support the findings of
Cawley et al. whomeasured the core temperatures of neonates
during scanning at 3 T and found no significant effects [13].
We must stress, however, that the babies included in this study
were “physiologically stable”, which may explain the absence
of serious adverse events during the scan procedure. Similar
studies are required in the future when acutely unwell and
particularly low-birth-weight premature babies will be
scanned.
At the planning stage of this study wewere prepared to take
image quality that was ‘no worse’ than that obtained from our
routine clinical scanning on a 1.5-T system as an acceptable
outcome. This ‘equivalence’ approach was justified by the
extra advantages in terms of safety by having the investiga-
tional 3-T neonatal scanner on the neonatal unit. Our results
show that the image quality was at least equivalent to 1.5 T in
the majority of cases (90%) and were judged to be better than
the 1.5-T images in 65% of cases. The investigational 3-T
neonatal scanner has the full range of MR sequences that we
would expect to use in the clinical environment, all of which
produce high-quality images. The next stage of the pro-
gramme is to see if this can be reproduced in babies that have
acute brain pathology. Once CE marking is obtained we will
start to perform standard-of-care neuroimaging on that scan-
ner. We will judge whether the optimised sequences devel-
oped through the study demonstrate the pathology or if further
scan parameter optimisations are necessary.
In conclusion, we describe a new class of high-field MR
scanner designed specifically for imaging neonates that is
small enough to be sited on neonatal units. Our initial assess-
ments of safety and technical performance are favourable and
the next stage is to move on to evaluate diagnostic perfor-
mance and diagnostic/clinical impact.
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